Annual Income Statements for ECARX
This table shows ECARX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for ECARX
No quarterly income statements for ECARX are available.
Annual Cash Flow Statements for ECARX
This table details how cash moves in and out of ECARX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Net Change in Cash & Equivalents |
|
-215 |
-2.31 |
-13 |
-47 |
-34 |
43 |
| Net Cash From Operating Activities |
|
-57 |
-142 |
-67 |
-172 |
-60 |
-94 |
| Net Cash From Continuing Operating Activities |
|
-57 |
-142 |
-67 |
-172 |
-60 |
-94 |
| Net Income / (Loss) Continuing Operations |
|
-68 |
-185 |
-233 |
-144 |
-138 |
-69 |
| Consolidated Net Income / (Loss) |
|
-68 |
-185 |
-233 |
-144 |
-138 |
-69 |
| Depreciation Expense |
|
9.07 |
10 |
11 |
12 |
21 |
20 |
| Non-Cash Adjustments To Reconcile Net Income |
|
-15 |
59 |
52 |
21 |
45 |
19 |
| Changes in Operating Assets and Liabilities, net |
|
8.09 |
-43 |
104 |
-62 |
12 |
-64 |
| Net Cash From Investing Activities |
|
-14 |
-188 |
-45 |
87 |
-8.12 |
-70 |
| Net Cash From Continuing Investing Activities |
|
-14 |
-188 |
-45 |
87 |
-0.29 |
-70 |
| Purchase of Property, Plant & Equipment |
|
-11 |
-13 |
-23 |
-8.88 |
-16 |
-12 |
| Acquisitions |
|
0.00 |
-181 |
-15 |
0.00 |
-7.45 |
0.00 |
| Purchase of Investments |
|
0.00 |
-7.64 |
-8.30 |
-52 |
-42 |
-93 |
| Sale of Property, Plant & Equipment |
|
0.00 |
0.00 |
0.25 |
0.31 |
0.22 |
1.01 |
| Divestitures |
|
- |
- |
- |
0.00 |
20 |
0.33 |
| Sale and/or Maturity of Investments |
|
0.00 |
14 |
4.26 |
33 |
45 |
32 |
| Other Investing Activities, net |
|
-3.38 |
0.00 |
-3.99 |
115 |
0.00 |
0.95 |
| Net Cash From Financing Activities |
|
175 |
333 |
95 |
41 |
36 |
204 |
| Net Cash From Continuing Financing Activities |
|
-142 |
333 |
95 |
41 |
36 |
204 |
| Repayment of Debt |
|
-26 |
-201 |
-298 |
-208 |
-264 |
-438 |
| Repurchase of Preferred Equity |
|
-159 |
72 |
0.00 |
0.00 |
-3.00 |
-29 |
| Repurchase of Common Equity |
|
-1.31 |
-1.57 |
- |
0.00 |
0.00 |
-0.62 |
| Payment of Dividends |
|
0.00 |
0.00 |
-20 |
-11 |
0.00 |
-1.00 |
| Issuance of Debt |
|
12 |
156 |
362 |
253 |
306 |
523 |
| Issuance of Preferred Equity |
|
32 |
506 |
23 |
0.00 |
- |
109 |
| Issuance of Common Equity |
|
0.00 |
0.00 |
6.34 |
0.00 |
0.00 |
43 |
| Other Financing Activities, net |
|
0.00 |
-198 |
22 |
6.85 |
-2.54 |
-1.81 |
| Effect of Exchange Rate Changes |
|
-1.54 |
-5.02 |
4.19 |
-2.03 |
-2.18 |
4.10 |
| Cash Interest Paid |
|
0.45 |
4.55 |
4.19 |
9.01 |
16 |
23 |
| Cash Income Taxes Paid |
|
0.01 |
1.97 |
0.00 |
0.28 |
1.78 |
3.22 |
Quarterly Cash Flow Statements for ECARX
No quarterly cash flow statements for ECARX are available.
Annual Balance Sheets for ECARX
This table presents ECARX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
2021 |
2022 |
2023 |
2024 |
2025 |
| Total Assets |
|
622 |
686 |
607 |
514 |
662 |
| Total Current Assets |
|
386 |
559 |
469 |
386 |
483 |
| Cash & Equivalents |
|
138 |
125 |
81 |
44 |
87 |
| Restricted Cash |
|
3.61 |
5.94 |
3.82 |
5.91 |
6.14 |
| Short-Term Investments |
|
- |
0.00 |
19 |
18 |
31 |
| Note & Lease Receivable |
|
22 |
26 |
7.70 |
2.29 |
5.96 |
| Accounts Receivable |
|
156 |
314 |
272 |
222 |
254 |
| Inventories, net |
|
35 |
26 |
23 |
32 |
62 |
| Prepaid Expenses |
|
31 |
62 |
62 |
62 |
36 |
| Plant, Property, & Equipment, net |
|
16 |
20 |
17 |
22 |
27 |
| Total Noncurrent Assets |
|
221 |
107 |
121 |
106 |
153 |
| Long-Term Investments |
|
212 |
51 |
42 |
2.16 |
62 |
| Goodwill |
|
- |
- |
0.00 |
3.50 |
3.69 |
| Intangible Assets |
|
4.87 |
6.50 |
25 |
42 |
40 |
| Other Noncurrent Operating Assets |
|
3.43 |
49 |
53 |
58 |
47 |
| Total Liabilities & Shareholders' Equity |
|
622 |
686 |
607 |
514 |
662 |
| Total Liabilities |
|
551 |
691 |
724 |
752 |
946 |
| Total Current Liabilities |
|
474 |
569 |
599 |
699 |
823 |
| Short-Term Debt |
|
166 |
151 |
170 |
269 |
369 |
| Accounts Payable |
|
119 |
245 |
300 |
290 |
297 |
| Accrued Expenses |
|
72 |
114 |
87 |
85 |
89 |
| Current Deferred & Payable Income Tax Liabilities |
|
0.00 |
3.13 |
2.22 |
2.79 |
1.02 |
| Other Current Liabilities |
|
117 |
57 |
39 |
51 |
67 |
| Total Noncurrent Liabilities |
|
77 |
122 |
125 |
53 |
123 |
| Long-Term Debt |
|
0.00 |
64 |
64 |
0.00 |
66 |
| Noncurrent Deferred & Payable Income Tax Liabilities |
|
- |
- |
0.00 |
2.07 |
1.70 |
| Other Noncurrent Operating Liabilities |
|
77 |
58 |
61 |
51 |
55 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
-645 |
-5.00 |
-117 |
-238 |
-283 |
| Total Preferred & Common Equity |
|
-644 |
-28 |
-129 |
-240 |
-283 |
| Total Common Equity |
|
-669 |
-28 |
-129 |
-240 |
-283 |
| Common Stock |
|
-25 |
858 |
859 |
895 |
958 |
| Retained Earnings |
|
-645 |
-831 |
-940 |
-1,124 |
-1,190 |
| Treasury Stock |
|
- |
- |
0.00 |
-1.02 |
-30 |
| Accumulated Other Comprehensive Income / (Loss) |
|
0.95 |
-56 |
-49 |
-9.21 |
-20 |
| Noncontrolling Interest |
|
-0.90 |
23 |
12 |
1.97 |
-0.81 |
Quarterly Balance Sheets for ECARX
No quarterly balance sheets for ECARX are available.
Annual Metrics And Ratios for ECARX
This table displays calculated financial ratios and metrics derived from ECARX's official financial filings.
| Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
356,466,693.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
356,466,693.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
-0.19 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
| Net Operating Profit after Tax (NOPAT) |
|
-46 |
-110 |
-165 |
-90 |
-85 |
-38 |
| Return On Investment Capital (ROIC_SIMPLE) |
|
- |
- |
-78.94% |
-77.03% |
-271.18% |
-25.36% |
| Earnings before Interest and Taxes (EBIT) |
|
-63 |
-164 |
-214 |
-131 |
-126 |
-49 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-45 |
-139 |
-203 |
-118 |
-105 |
-29 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
0.00 |
6.42 |
-309 |
-34 |
-74 |
-42 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
0.00 |
-116 |
27 |
-29 |
-39 |
-35 |
| Increase / (Decrease) in Invested Capital |
|
0.00 |
-116 |
144 |
-56 |
-11 |
4.12 |
| Book Value per Share |
|
$0.00 |
($2.83) |
($0.12) |
($0.38) |
($0.71) |
($0.83) |
| Tangible Book Value per Share |
|
$0.00 |
($2.85) |
($0.15) |
($0.46) |
($0.85) |
($0.96) |
| Total Capital |
|
0.00 |
263 |
209 |
117 |
31 |
151 |
| Total Debt |
|
0.00 |
166 |
214 |
235 |
270 |
435 |
| Total Long-Term Debt |
|
0.00 |
0.00 |
64 |
64 |
0.00 |
66 |
| Net Debt |
|
0.00 |
-188 |
32 |
88 |
200 |
249 |
| Capital Expenditures (CapEx) |
|
11 |
13 |
23 |
8.46 |
15 |
11 |
| Debt-free, Cash-free Net Working Capital (DFCFNWC) |
|
0.00 |
-64 |
9.12 |
-63 |
-112 |
-95 |
| Debt-free Net Working Capital (DFNWC) |
|
0.00 |
77 |
140 |
40 |
-44 |
29 |
| Net Working Capital (NWC) |
|
0.00 |
-89 |
-11 |
-130 |
-314 |
-340 |
| Net Nonoperating Expense (NNE) |
|
21 |
74 |
68 |
53 |
51 |
31 |
| Net Nonoperating Obligations (NNO) |
|
0.00 |
-213 |
32 |
88 |
200 |
249 |
| Total Depreciation and Amortization (D&A) |
|
18 |
26 |
11 |
12 |
21 |
20 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
($7.92) |
($2.79) |
($0.38) |
($0.20) |
| Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
239.30M |
337.41M |
336.64M |
338.66M |
| Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
($1.15) |
($2.79) |
($0.38) |
($0.20) |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
239.30M |
337.41M |
336.64M |
338.66M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
337.40M |
337.95M |
340.13M |
356.47M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-46 |
-110 |
-165 |
-90 |
-85 |
-38 |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
Quarterly Metrics And Ratios for ECARX
No quarterly metrics and ratios for ECARX are available.